Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics

Patients as Partners® Europe announces its dates, keynotes and topics for the European meeting of pharma and biotech R&D executives, patient advocates and technologists to drive the integration of patient engagement to advance medicine development.

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- The Conference Forum today announced the launch of the 9th annual Patients as Partners® Europe event, taking place on May 20-21, 2025 at Royal National Hotel in London, UK. The meeting offers an unparalleled opportunity to hear from pharma R&D and patient advocacy on how patient involvement gets done, how it can be truly integrated to reduce risk and inefficiencies, and how it can advance medicine development for all.

"Recognizing patients as experts on their conditions and enabling their voices to be heard more clearly and deeply ultimately leads to more successful clinical trials and better healthcare outcomes," said 2025 co-chair and patient advocate, Alfred Samuels.

The 2025 keynotes and featured speakers include:

• Patient advocate Harry Verbunt on the impact a clinical trial had on his life post-cancer diagnosis with suggestions for greater trial access.
• Patient advocate Peter DiBiaso on how to put patients at the center of the clinical research enterprise.
• Patient advocate Temi Olonisakin, MD, on patient perspectives on vital support and preferences in clinical research.
• Roche's Lea-Isabelle Proulx, PhD, on mastering protocol complexity to reduce patient burden.
• Johnson & Johnson Innovative Medicine's Beyza Klein on embedding an end-to-end patient engagement and advocacy approach into a matrix organization.
• Sanofi's Catherine Coulouvrat, MD, on utilizing patient experience data to assess tolerability of products.
• Chiesi Farmaceutici SpA's Marisa Minetti on leveraging patient archetypes to help in the development of study protocols.
• Azafaros' Gisela Linthorst on involving the patient community in early clinical trials despite limited resources.

Pharma companies presenting case studies include:

• AstraZeneca
• Boehringer-Ingelheim
• Chiesi Farmaceutici SpA
• GSK
• Johnson & Johnson Innovative Medicine
• Regeneron
• Roche
• Sanofi

"We are pleased to present a wide range of case studies from R&D on significant progress in partnering with patients to advance medicine development and to hear directly from patients on their experience in clinical trials," said Valerie Bowling, Executive Director, Conference Forum.

Key topics include:

• The future of patient-informed research
• Patient preferences and decentralized clinical trials
• Increasing representation in clinical trials
• The patient experience data landscape
• Turning patient insights into action
• Mapping and demonstrating value for patient engagement
• Patient burden-reducing solutions and technologies
• HTA/Regulatory requirements and patient engagement in drug development

About Patients as Partners® Europe:
Patients as Partners® Europe is co-produced with patients, the R&D industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement, access and diversity across the entire clinical development continuum. To learn more about Patients as Partners and access the full agenda, visit PatientsAsPartnersEU.com.

About the Conference Forum:
The Conference Forum is a life science industry research, conference development and marketing firm. The company brings the full spectrum of executives together to share ideas and information on how to advance efficient medicine development and delivery, patient access and inclusive representation. The firm produces trusted conferences, webinars, podcasts and digital editorial, and provides marketing services. To learn more, visit theconferenceforum.org.

SOURCE Patients as Partners EU